Amylyx Pharmaceuticals, Inc. (AMLX): Prognoz qilingan narxning foydaga nisbati
Neyrodegeneratsiyaga qarshi dori vositalariga bo'lgan yuqori talab Amylyx Pharmaceuticals (AMLX) kompaniyasining klinik sinovlarini kengaytirish xarajatlarini belgilaydi. Kompaniyaning kelajakdagi foyda ko'rsatkichiga nisbatan narx koeffitsiyenti ushbu investitsiyalar dinamikasini aks ettiradi, bunda 0.00 parametrning joriy holatini belgilaydi. Aktiv zararli emissiyalarni kamaytirish uchun yashil kimyo ekologik standartlariga rioya qilgan holda, Wolfram sindromiga qarshi kurashish uchun yangi molekulalarni sotib olishga tayanadi.
Amylyx Pharmaceuticals, Inc. (AMLX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Amylyx Pharmaceuticals|AMLX - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning o'z kapitaliga nisbati Amylyx Pharmaceuticals, Inc.|AMLX - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Amylyx|AMLX - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Amylyx Pharmaceuticals|Tezkor likvidlik koeffitsiyenti amylyx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
AMLX - Sof foyda|Kutilayotgan foyda Amylyx Pharmaceuticals|AMLX - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati amylyx.com|AMLX - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Amylyx|AMLX - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Amylyx Pharmaceuticals|AMLX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi amylyx.com|AMLX - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Amylyx Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Fundamental baholash:AMLX Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals (AMLX) kompaniyasini baholash dori vositalari uchun maxsus termal logistika xarajatlarini hisobga olgan holda, kutilayotgan daromadlar tahlilini talab qiladi. Ushbu koeffitsiyent joriy bozor kapitalizatsiyasini prognoz qilingan yillik sof foyda bilan bog'laydi. Kompaniyaning kutilayotgan P/E koeffitsiyentini kuzatish orqali investor hisobot davrlari orasidagi bozor kutuvlarining dinamikasini tahlil qilishi mumkin. Ushbu koeffitsiyentning pasayishi aktivlarning qadrsizlanganligini yoki biznesning ichki xatarlarini anglatishi mumkin, bu esa investitsiya strategiyasini zudlik bilan tuzatish imkonini beradi.
Amylyx Pharmaceuticals raqobatchilari tahlili
Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Narxning kutilayotgan foydaga nisbati|anavex.com - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori CBLL (CeriBell, Inc.)|PRTA: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati ALEC|ANNX (Annexon Biosciences Inc.) - Forvard P/E multiplikatori|omeros.com - Narxning kutilayotgan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Neurogene (NGNE)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati AC Immune SA|Forvard P/E multiplikatori VYGR (voyagertherapeutics.com)|Forvard P/E multiplikatori Neumora NMRA|Scilex Holding - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Kelajakdagi narxning foydaga nisbati|cogrx.com (CGTX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Assertio Therapeutics (ASRT)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Coya|Vistagen - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori OVID|Acumen Pharmaceuticals Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CervoMed Inc|ATHE: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Clene Nanomedicine|Kelajakdagi narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Prognoz qilingan narx-foyda nisbati|gracetx.com - Prognoz qilingan narxning foydaga nisbati|AIFF: Narxning kelajakdagi foydaga nisbati|Klotho Neurosciences - Forvard P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narxning kelajakdagi foydaga nisbati|Reviva Pharmaceuticals (RVPH) - Kelajakdagi narxning foydaga nisbati|MTVA (MetaVia Inc.) - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati NeurAxis, Inc|Kelajakdagi narxning foydaga nisbati HSDT|Forvard P/E multiplikatori PASG|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Athira ATHA|Addex Therapeutics - Forvard P/E multiplikatori|ALZN - Forvard P/E multiplikatori|Cyclerion (CYCN) - Kelajakdagi narxning foydaga nisbati|Protagenic (PTIX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Pasithea|Narxning kelajakdagi foydaga nisbati CRGT (Cortigent)|Kelajakdagi narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Prognoz qilingan narxning foydaga nisbati|ELYM: Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)
